Equasens: ANNUAL ORDINARY GENERAL MEETING - MEETING NOTICE - ON-LINE AVAILABILITY OF MEETING MATERIALS
Werte in diesem Artikel
Villers-lès-Nancy, 10 June 2024 - 6:00 p.m. (CET)
PRESS RELEASE
ANNUAL ORDINARY GENERAL MEETING
MEETING NOTICE
ON-LINE AVAILABILITY OF MEETING MATERIALS
EQUASENS hereby provides notice to shareholders of the Annual Ordinary General Meeting to be held on Thursday, June 27, 2024 at 5.30 pm at the Company’s registered office located in Villers-lès-Nancy (Technopôle de Nancy-Brabois - 5 Allée de Saint Cloud).
The original French language version of the agenda and the resolutions submitted by the Board of Directors to the Ordinary Annual General Meeting were published in the French publication for legal announcements (Bulletin des Annonces Légales Obligatoires) on 17 May, 2024 (https://www.journal-officiel.gouv.fr/pages/balo-annonce-unitaire/?q.id=id_annonce:20240517240156460).
The Meeting Notice was published on the June 7, 2024 in the BALO (https://www.journal-officiel.gouv.fr/pages/balo-annonce-unitaire/?q.id=id_annonce:20240607240238969) and in the Official Journal "Les Tablettes Lorraines” (https://www.tabletteslorraines.fr/annonce-legale/20240607130128-318031-000091248807) including the procedures for participating and voting and the main methods to exercise shareholders’ rights.
Both of these notices are available on the Company’s website: www.equasens.com.
Pursuant to article R. 22-10-23 of the French commercial code, EQUASENS has also made available, since June 5, 2024, all the documents and information prescribed by this article and the voting form on its website www.equasens.com - Section Investisseurs, Assemblée Générale tab. The English version of these documents is available on the company's website, by clicking on the EN icon in the Investors section: https://equasens.com/en/shareholders-meetings/ .
For the purpose of communications between the Company and its shareholders, it is strongly recommended that requests or documents be sent, in priority, by email, to the following address: actionnaires@equasens.com.
About Group Equasens
With more than 1,300 employees, Equasens Group is today a key player in the European healthcare sector, providing software solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, Hospital-at-Home structures, retirement homes, health centres) in both primary and secondary care sectors.
With operations in France, Germany, Great Britain, Belgium, Ireland, Italy, and Luxembourg, Equasens Group today brings together healthcare professionals within a unique ecosystem in France and Europe benefiting people by making available the very best of technology.
Listed on Euronext Paris™ - Compartment B
Indexes: MSCI GLOBAL SMALL CAP - GAÏA Index 2020 - CAC® SMALL and CAC® All-Tradable
Included in the Euronext Tech Leaders segment and the European Rising Tech label
Eligible for the Deferred Settlement Service ("Service à Règlement Différé” - SRD) and equity savings accounts invested in small and mid caps (PEA-PME)
ISIN: FR 0012882389 – Ticker Code: EQS
Get all the news about the Equasens Group www.equasens.com and on LinkedIn
CONTACTS
Analyst and Investor Relations:
Chief Administrative and Financial Officer: Frédérique SCHMIDT
Tel. +33 (0)3 83 15 90 67 - frederique.schmidt@equasens.com
Media Relations:
FIN’EXTENSO - Isabelle APRILE
Tel. +33 (0)6 17 38 61 78 - i.aprile@finextenso.fr
Attachment
Ausgewählte Hebelprodukte auf PHARMAGEST INTERACTIVE
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf PHARMAGEST INTERACTIVE
Der Hebel muss zwischen 2 und 20 liegen
Aktuelle PHARMAGEST INTERACTIVE Aktie News
Keine Nachrichten im Zeitraum eines Jahres in dieser Kategorie verfügbar.
Eventuell finden Sie Nachrichten, die älter als ein Jahr sind, im Archiv
PHARMAGEST INTERACTIVE Analysen
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für PHARMAGEST INTERACTIVE nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen
Keine Analysen gefunden.